A bacteriophage has a mechanism for producing a family of receptor-binding proteins that rivals the immunoglobulins in diversity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
McMahon, S.A. et al. Nat. Struct. Mol. Biol. 12, 886–892 (2005).
Liu, M. et al. Science 295, 2091–2094 (2002).
Weis, W.I., Taylor, M.E. & Drickamer, K. Immunol. Rev. 163, 19–34 (1998).
Blundell, C.D. et al. J. Biol. Chem. 278, 49261–49270 (2003).
Batchelor, M. et al. EMBO J. 19, 2452–2464 (2000).
Chothia, C. & Lesk, A.M. J. Mol. Biol. 196, 901–917 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Drickamer, K., Taylor, M. Targeting diversity. Nat Struct Mol Biol 12, 830–831 (2005). https://doi.org/10.1038/nsmb1005-830
Issue Date:
DOI: https://doi.org/10.1038/nsmb1005-830
This article is cited by
-
Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy
Nature Reviews Microbiology (2007)